Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Studies on the induction of hydrocephalus and spongy degeneration by cuprizone feeding and attempts to antidote the toxicity.
US patent office grants patent claiming dosing regimen for TECFIDERA™ (dimethyl fumarate)
Episode 23 with Professor Aksel Siva discussing radiologically isolated syndrome (RIS)
Treatment Choices in Optic Neuritis: Corticosteroids, Intravenous Immunoglobulin, Plasma Exchange, or Other?
Characterisation of microglia during de- and remyelination: can they create a repair promoting environment?
Cost-Effectiveness of Treatments for Relapsing Remitting Multiple Sclerosis: A French Societal Perspective.
Teva Receives Positive Outcome in Europe for Three-Times-a-Week COPAXONE® (Glatiramer Acetate) 40 mg/ml for the Treatment of Relapsing Forms of Multiple Sclerosis (RMS)
Spectrophotometric Determination of Serum Copper with Biscyclohexanoneoxalyldihydrazone
Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response.
New diagnostic criteria for multiple sclerosis: guidelines for research protocols.
Episode 39 with Dr. Joseph Berger on diagnostic dilemmas in MS
The role of natural killer cells in multiple sclerosis and their therapeutic implications.
Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study.
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial.
46th Annual WCBR Winter Conference on Brain Research
29th European Committee for Treatment and Research in Multiple Sclerosis Congress
Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort.
Gene expression in brain during cuprizone-induced demyelination and remyelination.
Episode 7 with Dr. Daniel Kantor on access to care
Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent.
Environmental factors in multiple sclerosis: Epstein-Barr virus, vitamin D, and cigarette smoking.
Dynamics of B-Cell Populations in CSF and Blood in Patients Treated with a Combination of Rituximab and Mitoxantrone.
Episode 20 with Dr. Jeffrey Cohen discussing two MS-related clinical trials
TECFIDERA prescribing information
Integrating Acupuncture Within a Wellness Intervention for Women With Multiple Sclerosis: A Feasibility Study.
Pages
« first
‹ previous
…
52
53
54
55
56
57
58
59
60
…
next ›
last »